Skip to main content

NAT 25mg Pill - white capsule/oblong, 18mm

Pill with imprint NAT 25mg is White, Capsule/Oblong and has been identified as Lenalidomide 25 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Lenalidomide is used in the treatment of Mantle Cell Lymphoma; Follicular Lymphoma; Anemia; Lymphoma; Marginal Zone Lymphoma and belongs to the drug classes miscellaneous antineoplastics, other immunosuppressants. Not for use in pregnancy. Lenalidomide 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NAT 25mg

Lenalidomide 25 mg NAT 25mg

Lenalidomide

Imprint
NAT 25mg
Strength
25 mg
Color
White
Size
18.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Miscellaneous antineoplastics, Other immunosuppressants
Pregnancy Category
X - Not for use in pregnancy
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
Manufacturer
Natco Pharma Limited
National Drug Code (NDC)
00480-1246

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.